Zydus Wellness Limited Earnings Summary — Q4 FY2026
Zydus Wellness Posts Record Quarterly Sales Amidst Seasonality Shift and Elevated Borrowings
Key Takeaways
- Revenue reached a record quarterly high of ₹1,485 Cr, up 62% YoY, indicating strong off-take of summer brands like Glucon-D.
- Operating Profit Margins (OPM) contracted to 18% from 21% YoY, despite the massive scale, suggesting input cost pressures.
- Net Profit fell slightly to ₹162 Cr compared to ₹172 Cr in the prior year's quarter, hindered by a sharp rise in interest and depreciation.
- Borrowings escalated significantly from ₹188 Cr in March 2025 to ₹3,203 Cr in March 2026, likely due to fresh asset acquisitions.
- The business remains highly seasonal, with the March quarter providing the bulk of annual operating profit compared to losses in Sep/Dec quarters.
- Inventory levels on the balance sheet nearly doubled YoY to ₹1,836 Cr, indicating a large build-up for the upcoming peak season.
- Compounded profit growth over the last 5 years remains negative (-2%), highlighting a struggle to translate revenue scale into earnings.
Management Guidance
Management remains focused on maintaining dominance in the Sugar Free (Sugar Substitute) and Glucon-D (Glucose) categories while attempting to scale Complan and Nycil.
Sentiment Shift
Stable
Outlook
The company's performance is heavily dependent on the summer season; however, the massive jump in fixed assets and borrowings suggests a strategic shift or major expansion that may impact long-term capital efficiency.
← Back to Zydus Wellness Limited AI analysis
Unlock the full report
Deep-dive sections, financial charts, AI chat and PDF export are available with Premium.
This summary is AI-generated from Zydus Wellness Limited's latest annual report and public disclosures. It is for informational purposes only and is not investment advice.